Literature DB >> 28882404

Health Related Quality of Life Following Radical Cystectomy: Comparative Analysis from the Medicare Health Outcomes Survey.

Brian R Winters1, Jonathan L Wright2, Sarah K Holt3, Atreya Dash3, John L Gore3, George R Schade3.   

Abstract

PURPOSE: Health related quality of life after radical cystectomy and ileal conduit is not well quantified at the population level. We evaluated health related quality of life in patients with bladder cancer compared with noncancer controls and patients with colorectal cancer using data from SEER (Surveillance, Epidemiology and End Results)-MHOS (Medicare Health Outcomes Survey).
MATERIALS AND METHODS: SEER-MHOS data from 1998 to 2013 were used to identify patients with bladder cancer and those with colorectal cancer who underwent extirpative surgery with ileal conduit or colostomy creation, respectively. A total of 166 patients with bladder cancer treated with radical cystectomy were propensity matched 1:5 to 830 noncancer controls and compared with 154 patients with colorectal cancer. Differences in Mental and Physical Component Summary scores as well as component subscores were determined between patients with bladder cancer, patients with colorectal cancer and noncancer controls.
RESULTS: SEER-MHOS patients were more commonly male and white with a mean ± SD age of 77 ± 6 years. Patients treated with radical cystectomy had significantly lower Physical Component Summary scores, select physical subscale scores and all mental subscale scores compared with noncancer controls. These findings were similar in the subset of 40 patients treated with radical cystectomy who had available preoperative and postoperative survey data. Global Mental Component Summary scores did not differ significantly between the groups. No significant differences were observed in global Mental Component Summary, Physical Component Summary or subscale scores between patients with bladder cancer and patients with colorectal cancer.
CONCLUSIONS: Patients with bladder cancer who undergo radical cystectomy have significant declines in multiple components of physical and mental health related quality of life vs noncancer controls, which mirror those of patients with colorectal cancer. Further longitudinal study is required to better codify the effectors of poor health related quality of life after radical cystectomy to improve patient expectations and outcomes.
Copyright © 2018 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Medicare; colostomy; cystectomy; quality of life; urinary bladder neoplasms

Mesh:

Year:  2017        PMID: 28882404     DOI: 10.1016/j.juro.2017.08.111

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

Review 1.  Perpetual role of brachytherapy in organ-sparing treatment for bladder cancer: a historical review.

Authors:  Elzbieta Van der Steen-Banasik; Bernard Oosterveld; Geert Smits; Els Atema; Marion Van Gellekom; Marie Haverkort; Andries Visser
Journal:  J Contemp Brachytherapy       Date:  2020-12-16

2.  Multi-country clinical practice patterns, including use of biomarkers, among physicians' treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC).

Authors:  Edward I Broughton; Kyna M Gooden; Katie L Mycock; Ivana Rajkovic; Gavin Taylor-Stokes
Journal:  BMC Urol       Date:  2022-02-26       Impact factor: 2.264

3.  Interferon gamma expression and mortality in unselected cohorts of urothelial bladder cancer patients.

Authors:  Christina Gillezeau; Naimisha Movva; Maaike van Gerwen; Karma Rabon-Stith; Norah Shire; Philip Zachary Brohawn; Emanuela Taioli; Jon Fryzek
Journal:  PLoS One       Date:  2022-08-30       Impact factor: 3.752

4.  Treatment and disease management patterns for bacillus Calmette-Guérin unresponsive nonmuscle invasive bladder cancer in North America, Europe and Asia: A real-world data analysis.

Authors:  Edward I Broughton; Danielle S Chun; Kyna M Gooden; Katie L Mycock; Ivana Rajkovic; Gavin Taylor-Stokes
Journal:  Curr Urol       Date:  2022-08-02

Review 5.  Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis.

Authors:  Mario Pones; David D'Andrea; Keiichiro Mori; Mohammad Abufraj; Marco Moschini; Eva Comperat; Shahrokh F Shariat
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

6.  How to assess and improve health-related quality of life in bladder cancer patients.

Authors:  Francesco Soria; Paolo Gontero
Journal:  Transl Androl Urol       Date:  2018-03

7.  Health-related quality of life in bladder cancer patients undergoing radical cystectomy and urinary stoma: still many gaps.

Authors:  Massimiliano Creta; Nicola Longo; Ciro Imbimbo; Vittorio Imperatore; Vincenzo Mirone; Ferdinando Fusco
Journal:  Transl Androl Urol       Date:  2018-03

Review 8.  The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future.

Authors:  Christopher J D Wallis; James W F Catto; Antonio Finelli; Adam W Glaser; John L Gore; Stacy Loeb; Todd M Morgan; Alicia K Morgans; Nicolas Mottet; Richard Neal; Tim O'Brien; Anobel Y Odisho; Thomas Powles; Ted A Skolarus; Angela B Smith; Bernadett Szabados; Zachary Klaassen; Daniel E Spratt
Journal:  Eur Urol       Date:  2020-09-04       Impact factor: 20.096

9.  Neoadjuvant Chemotherapy-Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study.

Authors:  Hongzhe Shi; Wen Zhang; Xingang Bi; Dong Wang; Zejun Xiao; Youyan Guan; Kaopeng Guan; Jun Tian; Hongsong Bai; Linjun Hu; Chuanzhen Cao; Weixing Jiang; Zhilong Hu; Jin Zhang; Yan Chen; Shan Zheng; Xiaoli Feng; Changling Li; Yexiong Li; Jianhui Ma; Yueping Liu; Aiping Zhou; Jianzhong Shou
Journal:  Cancer Res Treat       Date:  2021-02-10       Impact factor: 4.679

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.